High risk vs"metabolically healthyo" phenotype in juvenile obesity - Neck subcutaneous adipose tissue and serum uric acid are clinically relevant

Experimental and Clinical Endocrinology and Diabetes

Volumn 121, Issue 7, 2013, Pages 384-390

  Weghuber, D ^a   Zelzer, S ^b   Stelzer, I ^b   Paulmichl, K ^a   Kammerhofer, D ^a   Schnedl, W ^c   Molnar, D ^d   Mangge, H ^b  

^a Paracelsus Private Medical School Salzburg   (Austria)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c Practice for General Internal Medicine   (Austria)

^d UNIVERSITY OF PÉCS   (Hungary)

Author keywords

cardiovascular incidences; metabolic features; obesity

Indexed keywords

ADIPONECTIN; URIC ACID;

ADOLESCENT; ADULT; ANTHROPOMETRIC PARAMETERS; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; CHILD; CHILDHOOD OBESITY; COMPARATIVE STUDY; FEMALE; HIGH RISK POPULATION; HUMAN; INSULIN RESISTANCE; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBSERVATIONAL STUDY; ORAL GLUCOSE TOLERANCE TEST; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; SUBCUTANEOUS FAT; URIC ACID BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADIPONECTIN; ADOLESCENT; CAROTID ARTERY DISEASES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; NECK; OBESITY; PROSPECTIVE STUDIES; SUBCUTANEOUS FAT; URIC ACID;

EID: 84880073221     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0033-1341440     Document Type: Article

References (40)

1. Stewart S. T., Cutler D. M., Rosen A. B. Forecasting the Effects of Obesity and Smoking on U.S. Life Expectancy. NEJM: 2009; 361 2252 2260
2. Schmid A., Schneider H., Golay A. et al. Economic burden of obesity and its comorbidities in Switzerland. Soz Praventivmed: 2005; 50 87 94 (Pubitemid 40613401)
3. Ärnlöv J., Ingelsson E., Sundström J. et al. Impact of Body Mass Index and the Metabolic Syndrome on the Risk of Cardiovascular Disease and Death in Middle-Aged Men. Circulation: 2010; 121 230 236
4. Blüher M. The distinction of metabolically healthy' from unhealthy' obese individuals. Curr Opin Lipidol: 2010; 21 38 43
5. Tataranni P. Treatment of Obesity: Should We Target the Individual or Society? Current Pharmaceutical Design: 2003; 9 1151 1163 (Pubitemid 36582251)
6. Camhi S. M., Katzmarzyk P. T. Tracking of cardiometabolic risk factor clustering from childhood to adulthood. IJPO: 2010; 5 122 129
7. Cole T. J., Bellizzi M. C., Flegal K. M. et al. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ: 2000; 320 1240 1243 (Pubitemid 30240471)
8. Möller R., Tafeit E., Smolle K. H. et al. "Lipometero": determining the thickness of a subcutaneous fatty layer. Biosens Bioelectron: 1994; 9 xiii xvi
9. Calori G., Lattuada G., Piemonti L. et al. Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study. Diabetes Care: 2011; 34 210 215
10. Möller R., Horejsi R., Pilz S. et al. Evaluation of risk profiles by subcutaneous adipose tissue topography in obese juveniles. Obesity (Silver Spring): 2007; 15 1319 1324 (Pubitemid 46932488)
11. Kuk J. L., Ardern C. I. Are metabolically normal but obese individuals at lower risk for all-cause mortality? Diabetes Care: 2009; 32 2297 2299
12. Alberti K. G., Zimmet P., Shaw J. Metabolic syndrome - a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med: 2006; 23 469 480
13. Zimmet P., Alberti K. G., Serrano Ríos M. A new international diabetes federation worldwide definition of the metabolic syndrome: the rationale and the results. Rev Esp Cardiol: 2005; 58 1371 1376 (Pubitemid 43193350)
14. Steinberger J., Daniels S. R., Eckel R. H. et al. Progress and challenges in metabolic syndrome in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Circulation: 2009; 119 628 647
15. Kiechl S., Willeit J. The natural course of atherosclerosis. Part II: vascular remodelling. Bruneck Study Group. Arterioscler Thromb Vasc Biol: 1999; 19 1491 1498 (Pubitemid 29263019)
16. Pignoli P., Tremoli E., Poli A. et al. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation: 1986; 74 1399 1406 (Pubitemid 17189260)
17. Sims EA H. Characterization of the syndromes of obesity. In Diabetes mellitus and obesity. Edited by Brodoff B. N., Bleicher S. J. Baltimore, MD Williams and Wilkins: 1982; 219 226
18. Bell L. M., Byrne S., Thompson A. et al. Increasing body mass index z-score is continuously associated with complications of overweight in children, even in the healthy weight range. J Clin Endocrinol Metab: 2007; 92 517 522
19. Winkelmann B. R., Marz W., Boehm B. O. et al. Rationale and design of the LURIC study - a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease. Pharmacogenomics: 2001; 2 1 73
20. Evans E. W., Sonneville K. R. BMI report cards: will they pass or fail in the fight against pediatric obesity? Curr Opin Pediatr: 2009; 21 431 436
21. Matthews D. R., Hosker J. P., Rudenski A. S. et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia: 1985; 28 412 419 (Pubitemid 15018832)
22. Neumark-Sztainer D., Bauer K. W., Friend S. et al. Family weight talk and dieting: how much do they matter for body dissatisfaction and disordered eating behaviors in adolescent girls? J Adolesc Health: 2010; 47 270 276
23. Yeckel C. W., Taksali S. E., Dziura J. et al. The normal glucose tolerance continuum in obese youth: evidence for impairment in beta-cell function independent of insulin resistance. J Clin Endocrinol Metab: 2005; 90 747 754 (Pubitemid 40279191)
24. Taksali S. E., Caprio S., Dziura J. et al. High visceral and low abdominal subcutaneous fat stores in the obese adolescent: a determinant of an adverse metabolic phenotype. Diabetes: 2008; 57 367 371
25. Tan C. Y., Vidal-Puig A. Adipose tissue expandability: the metabolic problems of obesity may arise from the inability to become more obese. Biochem Soc Trans: 2008; 36 935 940
26. Nafiu O. O., Burke C., Lee J. et al. Neck circumference as a screening measure for identifying children with high body mass index. Pediatrics: 2010; 126 306 310
27. Kurtoglu S., Hatipoglu N., Mazicioglu M. M. et al. Neck circumference as a novel parameter to determine metabolic risk factors in obese children. Eur J Clin Invest: 2011; 42 623 630
28. Mangge H., Almer G., Haj-Yahya S. et al. Nuchal thickness of subcutaneous adipose tissue is tightly associated with an increased LMW/total adiponectin ratio in obese juveniles. Atherosclerosis: 2009; 203 277 283
29. Weiss R., Dufour S., Taksali S. E. et al. Prediabetes in obese youth: a syndrome of impaired glucose tolerance, severe insulin restistance, and altered myocellular and abdominal fat partitioning. Lancet: 2003; 362 951 957 (Pubitemid 37159290)
30. Klöting N., Fasshauer M., Dietrich A. et al. Insulin-sensitive obesity. Am J Physiol Endocrinol Metab: 2010; 299 506 515
31. Shulman G. I. Cellular mechanisms of insulin resistance. J Clin Invest: 2000; 106 171 176 (Pubitemid 30483118)
32. Stefan N., Kantartzis K., Machann J. et al. Identification and characterization of metabolically benign obesity in humans. Arch Intern Med: 2008; 168 1609 1616
33. Nobili V., Parola M., Alisi A. et al. Oxidative stress parameters in paediatric non-alcoholic fatty liver disease. Int J Mol Med: 2010; 26 471 476
34. Tsouli S. G., Liberopoulos E. N., Mikhailidis D. P. et al. Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander? Metabolism: 2006; 55 1293 1301 (Pubitemid 44354944)
35. Hongo M., Hidaka H., Sakaguchi S. et al. Association between serum uric acid levels and cardiometabolic risk factors among Japanese junior high school students. Circ J: 2010; 74 1570 1577
36. Baker J. F., Krishnan E., Chen L. et al. Serum uric acid and cardiovascular disease: recent developments, and where do they leave us? Am J Med: 2005; 118 816 826 (Pubitemid 41097455)
37. Cirillo P., Sato W., Reungjui S. et al. Uric acid, the metabolic syndrome, and renal disease. J Am Soc Nephrol: 2006; 17 165 168
38. Sangun Ö, Dündar B., Köşker M. et al. Prevalence of metabolic syndrome in obese children and adolescents using three different criteria and evaluation of risk factors. J Clin Res Pediatr Endocrinol: 2011; 3 70 76
39. Kantartzis K., Machann J., Schick F. et al. Effects of a lifestyle intervention in metabolically benign and malign obesity. Diabetologia: 2011; 54 864 868
40. Stefan N., Kantartzis K., Machann J. et al. Global trends in body-mass index. Lancet: 2011; 377 1917